Creation of novel bioactive agents on the basis of fragment evolution approach of natural products
Project/Area Number |
21603004
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Chemical biology
|
Research Institution | Yokohama City University |
Principal Investigator |
OIKAWA Masato 横浜市立大学, 生命ナノシステム科学研究科・生命ナノシステム科学研究科, 教授 (70273571)
|
Co-Investigator(Kenkyū-buntansha) |
SAKAI Ryuichi 北海道大学, 水産科学研究院, 教授 (20265721)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | グルタミン酸受容体 / リガンド / fragment evolution / 天然物 / X線結晶構造解析 |
Research Abstract |
Development of novel ligands, that specifically interact with receptors located at synapses of mammalian nervous system, is important to understand and control complex brain functions at a molecular level. We had synthetically developed IKM-159 as a specific AMPA receptor antagonist, and in the present study, the structure-activity relationships have been extensively studied. As a result, we found that(2R)-IKM159 is neuronally active, whereas the(2S)-isomer is inactive. Furthermore, the interactions with GluA2 subunit have been clarified by X-ray crystallography of(2R)-IKM159 in complex with GluA2 dimer.
|
Report
(4 results)
Research Products
(56 results)